Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes
Clinical trial NCT05227677 · COMPLETED
Trial details
- NCT number
- NCT05227677
- Sponsor
- Asahi Kasei Therapeutics Corporation
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-15
- Primary completion
- 2024-08-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.